novo nordisk semaglutide copycat risk is suing U.S. telehealth company Hims and Hers, alleging patent infringement over its planned release of a knockoff version of its Wegovy weight loss pill. Hims and Hers is pushing back, Novo Nordisk fights 'copycat' versions

Wondering how to safely stop GLP-1 meds like Ozempic or Wegovy

The present application relates to a process for the preparation of semaglutide

The first developed approach was the capability of generating, with manifold regression, humanoid avatars with accurate anthropometric dimensions

Learn how Ivim Healths weight loss program supports significant weight loss with personalized care, easy online consultations, and fast medication delivery.

And smart patent navigation

This helps to increase insulin release after eating, lower glucagon levels, and slow down the emptying of the stomach, all of which contribute to improved blood sugar levels